ArriVent BioPharma

AVBP

NASDAQHealth Care

Income Statement

Total Revenue$0

Operating Income$0

EBITDA$0

EBIT$-140.41M

Pre-tax Income$-127.46M

Net Income$-127.46M

Net Cash$498.65M

Cash Equivalent$176.08M

Total Debt$0

Net Debt$-498.65M

Book Value$257.65

Net Cash Per Share14650000.00

Book Value Per Share7.64

Return on Equity (ROE)-31.24%

Return on Assets (ROA)-29.27%

Return on Invested Capital (ROI)-31.24%

Net Profit Marginundefined

Current Ratio13.14

Quick Ratio13.13

Long-Term Debt / Equityundefined